Kiadis Pharma N.V.
Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded on June 12, 2015 and is headquartered in Amsterdam, the Netherlands.
Source : MTV
